Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé

2 results

  • Topics : Genital diseases
  • Active substance : iode
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Radiotherapy and physical agents (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
    • Interventional imaging (1)
  • Diseases and conditions (2)
  • Plus ...
    • Genital diseases (2)
    • Plus ...
      • Genital cancers (2)
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
    • Screening, prevention (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Public Health guideline (1)
Fabricant
  • alter (1)
  • inconnu (1)
Langue
  • Français (2)
Substance active
  • estramustine phosphate (1)
  • iode (2)
More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Appropriateness of systematic screening for prostatic cancer by prostate specific antigen (PSA)

    Public Health guideline - Posted on 1/1/1999 - Mis à jour le 6/12/2006
    Download abstract
    Add to my selection

Drugs, devices and medical acts - 1 result

  • High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer

    Health technology assessment - Posted on 28/1/2011
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
M43XKp2NPMfyAdsv